ProMIS Neurosciences is trading 7.33% up at $15.00 in after-hours trading, with no direct company-specific catalyst identified for the September 2, 2026 move.

  • The September 1 announcement covered upcoming conferences, investor meetings, PMN310, and PRECISE-AD.
  • It did not report earnings, regulatory approval, financing, or a partnership.
  • Broader markets were modestly positive, but that does not fully explain the stock’s larger gain.